Functional cross-antagonism between transcription factors FLI-1 and EKLF

被引:107
作者
Starck, J
Cohet, N
Gonnet, C
Sarrazin, S
Doubeikovskaia, Z
Doubeikovski, A
Verger, A
Duterque-Coquillaud, M
Morle, F
机构
[1] Ctr Genet Mol & Cellular, CNRS, UMR 5534, F-69622 Villeurbanne, France
[2] Inst Biol, CNRS, UMR 8526, F-59021 Lille, France
[3] Russian Acad Sci, Inst Biochem & Physiol Microorganisms, Moscow 142292, Russia
[4] Weis Ctr Res, Danville, PA 17822 USA
关键词
D O I
10.1128/MCB.23.4.1390-1402.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FLI-1 is an ETS family transcription factor which is overexpressed in Friend erythroleukemia and contributes to the blockage of differentiation of erythroleukemic cells. We show here that FLI-1 represses the transcriptional activity of the beta-globin gene promoter in MEL cells and interacts with two of its critical transactivators, GATA-1 and EKLF. Unexpectedly, FLI-1 enhances the stimulating activity of GATA-1 on a GATA-1-responsive promoter but represses that of EKLF on beta-globin and an EKLF-responsive artificial promoters. This repressive effect of FLI-1 requires the ETS DNA binding domain and its association with either the N- or C-terminal domain, which themselves interact with EKLF but not with GATA-1. Furthermore, the FLI-1 ETS domain alone behaves as an autonomous repression domain when linked to the Gal4 DNA binding domain. Taken together, these data indicate that FLI-1 represses EKLF-dependent transcription due to the repression activity of its ETS domain and its indirect recruitment to erythroid promoters by protein-protein interaction with EKLF. Reciprocally, we also show that EKLF itself represses the FLI-1-dependent megakaryocytic GPIX gene promoter, thus further suggesting that functional cross-antagonism between FLI-1 and EKLF might be involved in the control of the erythrocytic versus megakaryocytic differentiation of bipotential progenitors.
引用
收藏
页码:1390 / 1402
页数:13
相关论文
共 80 条
[1]  
ARIKANOVA I, 2002, ONCOGENE, V21, P1272
[2]   FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells [J].
Athanasiou, M ;
Mavrothalassitis, G ;
Sun-Hoffman, L ;
Blair, DG .
LEUKEMIA, 2000, 14 (03) :439-445
[3]  
Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525
[4]   Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts [J].
Barnache, S ;
Mayeux, P ;
Payrastre, B ;
Moreau-Gachelin, F .
BLOOD, 2001, 98 (08) :2372-2381
[5]   Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation [J].
Barnache, S ;
Wendling, F ;
Lacombe, C ;
Denis, N ;
Titeux, M ;
Vainchenker, W ;
Moreau-Gachelin, F .
ONCOGENE, 1998, 16 (23) :2989-2995
[6]   Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites [J].
Bastian, LS ;
Yagi, M ;
Chan, C ;
Roth, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18554-18560
[7]   Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1 [J].
Bastian, LS ;
Kwiatkowski, BA ;
Breininger, J ;
Danner, S ;
Roth, G .
BLOOD, 1999, 93 (08) :2637-2644
[8]   FRIEND VIRUS-INDUCED ERYTHROLEUKEMIA AND THE MULTISTAGE NATURE OF CANCER [J].
BENDAVID, Y ;
BERNSTEIN, A .
CELL, 1991, 66 (05) :831-834
[9]  
BIEKER JJ, 1995, MOL CELL BIOL, V15, P852
[10]   Transcriptional regulation of erythropoiesis: an affair involving multiple partners [J].
Cantor, AB ;
Orkin, SH .
ONCOGENE, 2002, 21 (21) :3368-3376